ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 195 filers reported holding ANIKA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 15.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,510,000 | +25.0% | 27,512 | -7.5% | 0.01% | +33.3% |
Q2 2019 | $1,208,000 | +166.7% | 29,735 | +254.1% | 0.01% | +200.0% |
Q4 2017 | $453,000 | -7.0% | 8,398 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $487,000 | +12.5% | 8,398 | -5.1% | 0.00% | 0.0% |
Q4 2016 | $433,000 | +0.9% | 8,849 | -1.3% | 0.00% | -25.0% |
Q3 2016 | $429,000 | -19.8% | 8,965 | -36.0% | 0.00% | -20.0% |
Q4 2015 | $535,000 | -88.0% | 14,012 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $4,460,000 | +920.6% | 14,012 | +5.9% | 0.01% | +25.0% |
Q2 2015 | $437,000 | -18.5% | 13,234 | +1.6% | 0.00% | 0.0% |
Q1 2015 | $536,000 | +4.3% | 13,028 | +3.2% | 0.00% | 0.0% |
Q4 2014 | $514,000 | -2.7% | 12,624 | -12.4% | 0.00% | 0.0% |
Q3 2014 | $528,000 | -17.6% | 14,416 | +4.2% | 0.00% | -33.3% |
Q2 2014 | $641,000 | +15.7% | 13,836 | +2.6% | 0.01% | +20.0% |
Q1 2014 | $554,000 | -18.4% | 13,484 | -33.9% | 0.01% | -28.6% |
Q4 2013 | $679,000 | +169.4% | 20,406 | +93.8% | 0.01% | +133.3% |
Q3 2013 | $252,000 | – | 10,528 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |